Literature DB >> 34470115

Marijuana use, fetal growth, and uterine artery Dopplers.

Ann M Bruno1,2, Nathan R Blue1,2, Amanda A Allshouse1, David M Haas3, Anthony L Shanks3, William A Grobman4, Hyagriv Simhan5, Uma M Reddy6, Robert M Silver1,2, Torri D Metz1,2.   

Abstract

OBJECTIVE: Marijuana (MJ) use is associated with adverse effects on fetal growth. We aimed to investigate the timing of suboptimal fetal growth onset in MJ-exposed pregnancies. In addition, we aimed to explore the relationship between MJ-exposure and both abnormal uterine artery (UtA) Doppler parameters and small for gestational age (SGA). STUDY
DESIGN: This was a secondary analysis of a prospective multicenter cohort that enrolled nulliparous individuals delivering non-anomalous fetuses beyond 20 weeks' gestation. Marijuana exposure was ascertained by self-report or clinical urine toxicology testing. Ultrasound estimated fetal weights (EFWs) were assessed in participants at both 16w0d-21w6d and 22w0d-29w6d. EFWs and birth weight (BW) were converted to weight percentiles (wPCT). EFW and BW wPCTs were calculated using population-based standards. Additionally, a customized standard designed to be applicable to both EFWs and BWs within the same model was also used to allow for EFW to BW percentile trajectories. The primary outcome, longitudinal wPCT, was compared between individuals with and without MJ use in a linear mixed-effects regression model adjusting for tobacco. For modeling, wPCT was smoothed across gestational age; MJ was estimated as an intercept and linear difference in the slope of gestational age. UtA Doppler notching, resistance index (RI), and pulsatility index (PI) at 16w0d-21w6d were compared using t-test and χ2. SGA at delivery was also compared.
RESULTS: Nine thousand one hundred and sixty-three individuals met inclusion criteria; 136 (1.5%) used MJ during pregnancy. Individuals who used MJ were more likely to be younger, identify as non-Hispanic Black, and have had less education. Fetuses exposed to MJ had lower wPCT beginning at 28 weeks using population-based and customized standards, when compared to those without exposure. UtA notching, PI, and RI were similar between groups. SGA was more frequent in neonates exposed to MJ using both population-based (22 vs. 9%, p<.001) and customized (25 vs. 14%, p<.001) curves.
CONCLUSIONS: MJ-exposed fetuses were estimated to be smaller than unexposed fetuses starting at 28 weeks' gestation across both growth standards without a difference in UtA Doppler parameters.

Entities:  

Keywords:  Marijuana; birth weight; fetal growth; uterine artery Doppler; weight percentile

Year:  2021        PMID: 34470115      PMCID: PMC9080638          DOI: 10.1080/14767058.2021.1960973

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  36 in total

Review 1.  First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55,974 women.

Authors:  L Velauthar; M N Plana; M Kalidindi; J Zamora; B Thilaganathan; S E Illanes; K S Khan; J Aquilina; S Thangaratinam
Journal:  Ultrasound Obstet Gynecol       Date:  2014-04-04       Impact factor: 7.299

2.  Prenatal Marijuana Use by Self-Report and Umbilical Cord Sampling in a State With Marijuana Legalization.

Authors:  Torri D Metz; Robert M Silver; Gwendolyn A McMillin; Amanda A Allshouse; Triniti L Jensen; Chanel Mansfield; Kennon Heard; Gregory L Kinney; Erica Wymore; Ingrid A Binswanger
Journal:  Obstet Gynecol       Date:  2019-01       Impact factor: 7.661

Review 3.  Endocannabinoid system and pregnancy.

Authors:  Fernando Correa; Manuel L Wolfson; Paula Valchi; Julieta Aisemberg; Ana María Franchi
Journal:  Reproduction       Date:  2016-12       Impact factor: 3.906

Review 4.  Maternal Marijuana Use and Adverse Neonatal Outcomes: A Systematic Review and Meta-analysis.

Authors:  Shayna N Conner; Victoria Bedell; Kim Lipsey; George A Macones; Alison G Cahill; Methodius G Tuuli
Journal:  Obstet Gynecol       Date:  2016-10       Impact factor: 7.661

Review 5.  Customized growth charts: rationale, validation and clinical benefits.

Authors:  Jason Gardosi; Andre Francis; Sue Turner; Mandy Williams
Journal:  Am J Obstet Gynecol       Date:  2018-02       Impact factor: 8.661

6.  Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012).

Authors:  Juliana Gevaerd Martins; Joseph R Biggio; Alfred Abuhamad
Journal:  Am J Obstet Gynecol       Date:  2020-05-12       Impact factor: 8.661

Review 7.  Marijuana use in pregnancy and lactation: a review of the evidence.

Authors:  Torri D Metz; Elaine H Stickrath
Journal:  Am J Obstet Gynecol       Date:  2015-05-15       Impact factor: 8.661

8.  Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity.

Authors:  Torri D Metz; Amanda A Allshouse; Carol J Hogue; Robert L Goldenberg; Donald J Dudley; Michael W Varner; Deborah L Conway; George R Saade; Robert M Silver
Journal:  Am J Obstet Gynecol       Date:  2017-05-31       Impact factor: 8.661

9.  Customised and Noncustomised Birth Weight Centiles and Prediction of Stillbirth and Infant Mortality and Morbidity: A Cohort Study of 979,912 Term Singleton Pregnancies in Scotland.

Authors:  Stamatina Iliodromiti; Daniel F Mackay; Gordon C S Smith; Jill P Pell; Naveed Sattar; Debbie A Lawlor; Scott M Nelson
Journal:  PLoS Med       Date:  2017-01-31       Impact factor: 11.069

Review 10.  Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis.

Authors:  J K L Gunn; C B Rosales; K E Center; A Nuñez; S J Gibson; C Christ; J E Ehiri
Journal:  BMJ Open       Date:  2016-04-05       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.